Trial intelligence / Profile preview

Horizontal Transmission of Rotarix in Twins

NCT00396630Phase 3Completed

Sponsor
GSK
Start
Jan 2007
Primary completion
Jan 2008
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in rotavirus infection comparing Rotarix Group with Placebo Group (2 arms). Primary endpoint: Presence of Rotavirus Vaccine Strain in Any Stool Sample From Twin Receiving Placebo. Started Jan 2007; status: completed.

02

Drugs

rotavirus vaccine, live, oral
03

Conditions

rotavirus infection

Beyond the preview

Go deeper on NCT00396630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00396630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call